Immune determinants of covid-19 disease presentation and severity

acknowledgements

I thank clinical colleagues, lab members and collaborators for fruitful discussions. I also 

acknowledge the scientific community for openly engaging in discussions on social 

media, for sharing ideas and collaborating to mitigate the damage of this ongoing crisis.

Competing interests

The author is a cofounder of Cytodelics AB, Stockholm, Sweden, and is scientific advisor 

for Scailyte AG, Zurich, Swizerland, and Kancera AB, Stockholm, Sweden.

additional information

Correspondence should be addressed to P.B.

Peer review information Hannah Stower was the primary editor on this article and 

managed its editorial process and peer review in collaboration with the rest of the 

editorial team.

Reprints and permissions information is available at 

www.nature.com/reprints

.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in 

published maps and institutional affiliations.

© Springer Nature America, Inc. 2021

Nature MeDICINe

 | VOL 27 | JanUaRy 2021 | 28–33 | 

www.nature.com/naturemedicine

33

---